Orthogonal Polarisation Study in Young, Elderly and Type 2 Diabetics
NCT ID: NCT01476384
Last Updated: 2014-04-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
45 participants
INTERVENTIONAL
2010-10-31
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Microvascular Dilatation After Endogenous Induced Hyperinsulinemia
NCT00742456
Effects of Prebiotics on GLP-1 in Type 2 Diabetes
NCT02569684
Role of Angiotensin II in Insulin-induced Microvascular Activity
NCT01024543
Glucose Variability in Subclinical Hypertrophy
NCT02748434
Lifestyle Control of Postprandial Hyperglycemia
NCT02683135
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
FCD is a very sensitive parameter for determining the status of nutritive perfusion to the tissue. So far, one of the most easily accessible sites in humans for peripheral perfusion monitoring is the mouth. OPS produces excellent images of the sublingual microcirculation by placing the probe under the tongue. Movement artifacts, semiquantitative measure of perfusion, the presence of various secretions such as saliva and blood, observer-related bias, and malfunction of the apparatus are some of the limitations of the technique.
In the present study we will investigate the impact of postprandial insulin release on microvascular recruitment in the oral cavity.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Glucose drink
75 gram glucose, dissolved in 250 ml water
Glucose
Glucose drink: 75 gram dextrose monohydrate, dissolved in 250 ml water
Placebo
250 ml water
Placebo
250 ml water
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Glucose
Glucose drink: 75 gram dextrose monohydrate, dissolved in 250 ml water
Placebo
250 ml water
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged between 20-30 or 65-80 years
* BMI \< 30 kg/m2
* Non insulin-dependent Diabetes mellitus type 2 patients. Use of oral anti-diabetic agents (TZD's, Metformin and/or a sulfonylurea derivative) is allowed.
Exclusion Criteria
* Smoking
* Hypertension (according to WHO criteria)18
* Use of medication, except for oral blood glucose lowering medication
* All co morbidities interacting with mobility and muscle metabolism of the lower limbs (e.g. arthrosis, arthritis, spasticity/rigidity, all neurological disorders and paralysis).
* HbA1c \> 10.0%
* Diagnosed impaired renal or liver function
* Obesity (BMI\>30 kg/m2)
* Cardiac disease or cardiovascular problems in history
* Overt diabetic complications
20 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maastricht University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
LJC van Loon, Professor
Role: PRINCIPAL_INVESTIGATOR
Maastricht University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maastricht University Medical Center+
Maastricht, Limburg, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Groen BB, Hamer HM, Snijders T, van Kranenburg J, Frijns D, Vink H, van Loon LJ. Skeletal muscle capillary density and microvascular function are compromised with aging and type 2 diabetes. J Appl Physiol (1985). 2014 Apr 15;116(8):998-1005. doi: 10.1152/japplphysiol.00919.2013. Epub 2014 Feb 27.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MET 10-3-050
Identifier Type: REGISTRY
Identifier Source: secondary_id
MEC 10-3-050
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.